Position in NVS
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$1,175,870
+$152,904 QoQ
Shares Held
7,503
+12.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#577
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. NVS ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,175,870 | 7,503 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $1,022,966 | 6,697 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $797,440 | 5,784 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $720,324 | 5,617 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $668,096 | 5,521 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $614,923 | 5,516 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $534,621 | 5,494 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $726,236 | 6,314 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $727,334 | 6,832 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $681,269 | 7,043 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $700,731 | 6,940 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $599,751 | 5,888 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $308,784 | 3,060 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $276,276 | 3,003 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $299,557 | 3,302 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $268,771 | 3,536 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $285,880 | 3,382 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $305,721 | 3,484 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $296,785 | 3,393 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $397,369 | 4,859 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $282,661 | 3,098 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $280,203 | 3,278 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $303,498 | 3,214 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $271,836 | 3,126 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $276,867 | 3,170 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $247,020 | 2,996 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||